The RE firm will establish a 2°C roadmap for its Full Service Centers aimed at reducing carbon emissions (PRESS RELEASE)…
20-6-2013 — /europawire.eu/ — AstraZeneca and Bristol-Myers Squibb announced today top-line results of the Phase IV SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular…